Healthcare -
Biotechnology - NASDAQ - GB
$ 15.16
1.95 %
$ 2 B
Market Cap
-9.97
P/E
CNTA - STOCK-BASED COMPENSATION
Stock-based Compensation CNTA - Centessa Pharmaceuticals plc
29.4 M
LAST VALUE
40.68%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR